当前位置：北京方程嘉鸿科技有限公司>>ELISA试剂盒>>大鼠ELISA试剂盒>>抗利尿激素/血管加压素

抗利尿激素/血管加压素

返回列表页

参考价

面议

具体成交价以合同协议为准

产品型号

品牌

厂商性质经销商

所在地北京市

在线询价收藏产品查看联系电话

联系方式：陈丹查看联系方式

更新时间：2017-04-12 09:08:26浏览次数：233次

联系我时，请告知来自智慧城市网

产品分类 品牌分类

  ELISA试剂盒

猪ELISA试剂盒

大鼠ELISA试剂盒

小鼠ELISA试剂盒

人ELISA试剂盒科研用

全部产品列表

暂无信息

北京方程嘉鸿科技有限公司

经营模式：经销商

商铺产品：9996条

所在地区：北京北京市

联系人：陈丹（销售部）

询价 给他留言

产品简介

北京方程生物公司经营销售抗利尿激素/血管加压素/*加压素（ADH/VP/AVP）ELISA试剂盒，可以提供免费代测，送检赠京东卡活动正在进行中，详情咨询销售人员

详细介绍

CysLTs

试剂盒名称:抗利尿激素/血管加压素/*加压素(ADH/VP/AVP)ELISA试剂盒

英文名：Human cysteinyl leukotrienes,CysLTs

品牌:BIOFINE
种属:大鼠ELISA试剂盒
检测波长:450nm
所需样本体积: 50-100ul
适用范围:仅供科研
保存及有效期:2-8℃，六个月，-20℃一年
检测目的:用于测定血清，血浆及相关液体抗利尿激素/血管加压素/*加压素(ADH/VP/AVP)含量。适合检测包括血清、血浆、尿液、胸腹水、灌洗液、脑脊液、细胞培养上清、组织匀浆等标本。

contains the standard concentration of analyte will be prepared. Unknowns that generate a signal that is stronger than the known sample are "positive." Those that generate weaker signal are "negative." Doctor Dennis E Bidwell and Alister Voller created the test. History Before the development of the ELISA, the only option for conducting an immunoassay was radioimmunoassay, a technique using radioactively-labeled antigens or antibodies. In radioimmunoassay, the radioactivity provides the signal, which indicates whether a specific antigen or antibody is present in the sample. Radioimmunoassay was first described in a paper by Rosalyn Sussman Yalow and Solomon Berson published in 1960.[5] Because radioactivity poses a potential health threat, a safer alternative was sought. A suitable alternative to radioimmunoassay would substitute a non-radioactive signal in place of the radioactive signal. When enzymes (such as peroxidase) react with appropriate substrates (such as ABTS or 3,3’,5,5’-Tetramethylbenzidine), a change in color occurs, which is used as a signal. However, the signal has to be associated with the presence of antibody or antigen, which is why the enzyme has to be linked to an appropriate antibody. This linking process was independently developed by Stratis Avrameas and G.B. Pierce.[6] Since it is necessary to remove any unbound antibody or antigen by washing, the antibody or antigen has to be fixed to the surface of the container; i.e., the immunosorbent has to be prepared. A technique to accomplish this was published by Wide and Jerker Porath in 1966.[7] In 1971, Peter Perlmann and Eva Engvall at Stockholm University in Sweden, and Anton Schuurs and Bauke van Weemen in The Netherlands independently published papers that synthesized this knowledge into methods to perform EIA/ELISA.[8][9]

/*加压素(ADH/VP/AVP)IL-4是一种由活化的T细胞产生的细胞因子，以往称为B细胞生长因子1。在B细胞生长的早期活化B细胞，并使被抗原、抗IgM或脂多糖活化的B细胞进入细胞周期G1期。IL-4增强MHCII类抗原的表达和CD23（FceRII）在B细胞上的表达，诱导同种型（isotype）转换，如促使小鼠B细胞从分泌IgM、IgG3、 IgG2b转变成分泌IgG1、IgG2a、IgA和IgE。也增强单个核吞噬细胞表达MHCII类抗原，但对炎症性细胞因子（如IL-1,TNF,IL-8）的释放和这些细胞的杀菌活性有抑制作用。IL-4 也活化细胞毒性 T细胞，它被认为是典型的由TH2细胞产生的细胞因子，对于T,B淋巴细胞的发育以及驱动体液免疫反应和抗体产生都是十分重要的。

/*加压素(ADH/VP/AVP)

小扁豆素结合型甲胎蛋白/甲胎蛋白异质体1(AFP-L1)

抗核仁抗体(ANA)

shenbing蛋白(nephrin)

单核细胞增多性李斯特菌素O((LLO)

松弛肽/松弛素(RLN)

干细胞因子/肥大细胞生长因子(SCF/MGF)

胰高血糖素(GC)

变肾上腺素(MN)

前列腺素F(PGF)

白血病抑制因子受体(LIFR)

破骨细胞分化因子(ODF)